Trials / Completed
CompletedNCT03505892
A Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)
A Real-world, Prospective, Observational Study to Investigate the Clinical REsponses in Ankylosing Spondylitis Patients on Adalimumab Therapy in Taiwan (EAST)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 28 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objectives of this prospective observational study is to explore 1-year clinical response via both Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Ankylosing Spondylitis Disease Activity Score (ASDAS) after initiation of adalimumab therapy in AS patients from routine clinical practices in Taiwan.
Conditions
Timeline
- Start date
- 2018-06-05
- Primary completion
- 2021-10-25
- Completion
- 2021-10-25
- First posted
- 2018-04-23
- Last updated
- 2023-07-20
Locations
1 site across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03505892. Inclusion in this directory is not an endorsement.